Why is Remus Pharma. falling/rising?

As of 29-Sep, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 734.40, which reflects a decrease of Rs. 25.6 or 3.37%. The stock has hit a new 52-week low of Rs. 725.3 today and has underperformed its sector by 3.51%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has dropped by 8.03%, and its year-to-date performance shows a significant decline of 41.19%. There is also a notable decrease in investor participation, with delivery volume falling by 57.87% compared to the 5-day average, indicating a lack of interest among investors.
In the broader market context, the Sensex has shown a decline of only 2.25% over the past week, suggesting that Remus Pharmaceuticals is underperforming relative to the benchmark. While the Sensex has gained 4.19% year-to-date, Remus Pharmaceuticals has faced substantial losses, further highlighting its struggles in comparison to the overall market. The absence of any positive factors in the provided data indicates that the stock's recent movement is primarily influenced by negative sentiment and poor performance metrics, leading to its current downward trajectory.